Increased use of antimicrobial medication in bulimia nervosa and binge-eating disorder prior to the eating disorder treatment

2016 ◽  
Vol 49 (6) ◽  
pp. 542-552 ◽  
Author(s):  
Anu Raevuori ◽  
Laura Lukkariniemi ◽  
Jaana T. Suokas ◽  
Mika Gissler ◽  
Jaana M. Suvisaari ◽  
...  
Keyword(s):  
Eating Disorder ◽  
Bulimia Nervosa ◽  
Binge Eating ◽  
Binge Eating Disorder ◽  
Eating Disorder Treatment ◽  
Disorder Treatment

scholarly journals Weight Change over the Course of Binge Eating Disorder Treatment: Relationship to Binge Episodes and Psychological Factors

Obesity ◽  
2018 ◽  
Vol 26 (5) ◽  
pp. 838-844 ◽  
Author(s):  
Carly R. Pacanowski ◽  
Tyler B. Mason ◽  
Ross D. Crosby ◽  
James E. Mitchell ◽  
Scott J. Crow ◽  
...  
Keyword(s):  
Eating Disorder ◽  
Binge Eating ◽  
Binge Eating Disorder ◽  
Weight Change ◽  
Psychological Factors ◽  
Treatment Relationship ◽  
Eating Disorder Treatment ◽  
Disorder Treatment ◽  
Binge Eating Disorder Treatment

scholarly journals Overeaters Anonymous: An Overlooked Intervention for Binge Eating Disorder

2021 ◽  
Vol 18 (14) ◽  
pp. 7303
Author(s):  
Brenna Bray ◽  
Boris C. Rodríguez-Martín ◽  
David A. Wiss ◽  
Christine E. Bray ◽  
Heather Zwickey
Keyword(s):  
Social Support ◽  
Eating Disorder ◽  
Binge Eating ◽  
Binge Eating Disorder ◽  
Empirical Support ◽  
Twelve Step ◽  
Overeaters Anonymous ◽  
Eating Disorder Treatment ◽  
Disorder Treatment ◽  
Binge Eating Disorder Treatment

The purpose of this communication is to provide an overview as well as the strengths and weaknesses of Overeaters Anonymous (OA) as an intervention for binge eating disorder treatment. Binge eating disorder is associated with low remission rates, high relapse rates, treatment dissatisfaction, and high rates of failure to receive treatment attributed to stigma, misconceptions, lack of diagnosis, access to care, and inadequate insurance coverage. New interventions are needed that can overcome these barriers. OA is a twelve-step program and established fellowship for individuals who self-identify as having problematic relationships with food or eating. OA can be referred clinically or sought out by an individual confidentially, without a diagnosis, and free of charge. OA’s Nine Tools, Twelve Steps, and Twelve Traditions can provide structure, social support, and open, anonymous sharing that fosters a sense of connection and belonging. This may provide benefit to individuals who value structure and social support in their recovery. The tradition of anonymity may also create some challenges for conducting research and may explain the shortage of empirical support. This commentary reviews existing research findings on the effectiveness of twelve-step interventions and OA. Common misunderstandings about and within OA are also addressed and OA’s limitations are discussed. Overall, OA provides a promising option for binge eating disorder treatment that warrants clinical research on its feasibility and efficacy in a way that respects and protects its tradition of anonymity.

Pharmacotherapy for Eating Disorders

2017 ◽  
Author(s):  
Susan McElroy ◽  
Anna I. Guerdjikova ◽  
Nicole Mori ◽  
Paul E. Keck
Keyword(s):  
Eating Disorders ◽  
Anorexia Nervosa ◽  
Eating Disorder ◽  
Mental Disorders ◽  
Bulimia Nervosa ◽  
Binge Eating ◽  
Binge Eating Disorder ◽  
Night Eating Syndrome ◽  
Night Eating

This chapter addresses the pharmacotherapy of the eating disorders (EDs). Many persons with EDs receive pharmacotherapy, but pharmacotherapy research for EDs has lagged behind that for other major mental disorders. This chapter first provides a brief rationale for using medications in the treatment of EDs. It then reviews the data supporting the effectiveness of specific medications or medication classes in treating patients with anorexia nervosa (AN), bulimia nervosa (BN), binge eating disorder (BED), and other potentially important EDs, such as night eating syndrome (NES). It concludes by summarizing these data and suggesting future areas for research in the pharmacotherapy of EDs.

Pharmacotherapy of the Eating Disorders

2010 ◽  
pp. 416-451 ◽  
Author(s):  
Susan L. McElroy ◽  
Anna I. Guerdjikova ◽  
Anne M. O’Melia ◽  
Nicole Mori ◽  
Paul E. Keck
Keyword(s):  
Eating Disorders ◽  
Anorexia Nervosa ◽  
Eating Disorder ◽  
Mental Disorders ◽  
Bulimia Nervosa ◽  
Binge Eating ◽  
Binge Eating Disorder ◽  
Night Eating Syndrome ◽  
Night Eating

Many persons with eating disorders (EDs) receive pharmacotherapy, but pharmacotherapy research for EDs has lagged behind that for other major mental disorders. In this chapter, we first provide a brief rationale for using medications in the treatment of EDs. We then review the data supporting the effectiveness of specific medications or medication classes in treating patients with anorexia nervosa (AN), bulimia nervosa, binge eating disorder (BED), and other potentially important EDs, such as night eating syndrome (NES) and sleep-related eating disorder (SRED). We conclude by summarizing these data and suggesting future areas for research in the pharmacotherapy of EDs.

Sign in / Sign up

Export Citation Format

Share Document